Cambridge, MA, United States of America

Jason D Brubaker

This inventor holds 47 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 26 EPO patents, primarily in Kinase Inhibitors. Top assignees: Merck Sharp + Dohme Corp., Blueprint Medicines Corporation, Harvard College. Active years: 2010-2026.

USPTO Granted Patents = 47 

% Patents Active = 95.7

 

 

Average Co-Inventor Count = 5.1

ph-index = 10

Forward Citations = 282(Granted Patents)


Location History:

  • Cheshire, CT (US) (2010 - 2021)
  • Cambridge, MA (US) (2013 - 2024)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
MAP4K1
EGFR
IRAK4
Janus Kinase
Activin Receptor
RET
Pyrrolopyridines
Tetracyclines
Pyrazoles
Aminopyrazoles
Bicyclic Diamines
Notch Inhibitors
47 patents (USPTO):Explore Patents

Title: Jason D Brubaker - Innovative Inventor from Cambridge

Introduction: Jason D Brubaker is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: Jason D Brubaker holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Jason D Brubaker has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Jason D Brubaker has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Jason D Brubaker's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, leaving a lasting impact on the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…